Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transpla
![UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML | UCSF Helen Diller Family Comprehensive Cancer Center UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML | UCSF Helen Diller Family Comprehensive Cancer Center](https://cancer.ucsf.edu/sites/cancer.ucsf.edu/files/images/article/UCSF_03072018_BMT_Gaensler_0553.jpeg)
UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML | UCSF Helen Diller Family Comprehensive Cancer Center
![Lloyd E. Damon's research works | University of California, San Francisco, CA (UCSF) and other places Lloyd E. Damon's research works | University of California, San Francisco, CA (UCSF) and other places](https://www.researchgate.net/publication/348753222/figure/fig1/AS:1023042914353162@1620923846513/Segmented-linear-regression-of-IV-antibiotics-days-of-therapy-DOT-per-1-000-patient_Q320.jpg)